GOLDMAN SACHS GROUP INC
Position in FTXH — First Trust Nasdaq Pharmaceuticals ETF
CIK 886982
NEW YORK, NY
All Filings in FTXH
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-09-30 FTXH | $904,236 | 31,702 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 FTXH | $824,894 | 32,186 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 FTXH | $535,285 | 19,472 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 FTXH | $469,917 | 17,425 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 FTXH | $1,379,619 | 47,842 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 FTXH | $1,811,644 | 66,497 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 FTXH | $1,248,148 | 44,564 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 FTXH | $1,655,240 | 62,192 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 FTXH | $907,382 | 35,489 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 FTXH | $216,042 | 8,250 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 FTXH | $549,689 | 20,039 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 FTXH | $481,737 | 20,039 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 FTXH | $529,650 | 20,039 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 FTXH | $533,217 | 20,039 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 FTXH | $542,255 | 20,039 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 FTXH | $516,785 | 20,039 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 FTXH | $518,609 | 20,039 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 FTXH | $512,196 | 20,039 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||